GlassScriptPhysician profile
Heather M Quist
NPI 1861888729
$4,280.43
in general payments reported to CMS, 2019-2025
38 companies · $1,070 in 2025
The $1,070 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $604 · 2023: $1,166 · 2024: $1,246 · 2025: $1,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,482.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $802.05 | 2022-2025 | |
| Novo Nordisk INC | $650.02 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $413.63 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $368.72 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.07 | 2022-2025 | Jardiance |
| Glaxosmithkline, LLC. | $172.34 | 2022-2025 | Shingrix, Bexsero, Arexvy |
| Teleflex LLC | $154.00 | 2024 | Urolift |
| Neurocrine Biosciences, INC. | $117.95 | 2025 | |
| Abbott Laboratories | $105.51 | 2023-2025 | Freestyle Libre 3 |
| Lundbeck LLC | $105.08 | 2023-2025 | Rexulti, Vyepti |
| Astrazeneca Pharmaceuticals LP | $104.00 | 2022-2025 | Airsupra, Breztri |
| Exact Sciences Corporation | $100.36 | 2023-2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $97.63 | 2023-2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $85.95 | 2024-2025 | Spravato, Xarelto |
| Otsuka America Pharmaceutical, INC. | $83.07 | 2022-2023 | Rexulti |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $78.51 | 2022-2023 | Intellis Adaptivestim |
| Amgen INC. | $78.21 | 2024-2025 | Repatha, Otezla, Repatha |
| Merck Sharp & Dohme LLC | $55.92 | 2022-2023 | Verquvo, Belsomra, Steglatro |
| Dexcom, INC. | $53.10 | 2024 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $40.45 | 2022-2023 | Quviviq |
| Corium, LLC | $36.74 | 2023 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $36.13 | 2023 | Trintellix |
| Seqirus USA INC | $35.99 | 2024 | Flucelvax, Fluad |
| Bayer Healthcare Pharmaceuticals INC. | $32.76 | 2022-2025 | |
| Tris Pharma INC | $32.56 | 2023-2025 | Dyanavel Xr |
| Nevro Corp. | $26.40 | 2023 | Senza |
| Radius Health, INC. | $26.06 | 2025 | Tymlos |
| Astellas Pharma US INC | $24.52 | 2023 | Veozah |
| Edwards Lifesciences Corporation | $23.73 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Itamar Medical INC | $22.51 | 2025 | Watchpatone |
| Neos Therapeutics, LP | $21.49 | 2024 | Adzenys Xr-Odt |
| Collegium Pharmaceutical, INC. | $17.91 | 2025 | Jornay Pm |
| Esperion Therapeutics, INC. | $17.65 | 2024 | Nexletol |
| Alexion Pharmaceuticals, INC. | $16.65 | 2023 | Strensiq |
| Phadia US INC. | $16.57 | 2023 | Immunocap |
| Kowa Pharmaceuticals America, INC. | $15.40 | 2024 | Zoryve |
| Almatica Pharma LLC | $14.69 | 2023 | Loreev Xr |
| Globus Medical, INC. | $14.10 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Quist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.